EconPapers    
Economics at your fingertips  
 

Three Important Studies for Cancer Gene Diagnosis

Shuichi Shinmura ()

Chapter Chapter 6 in The First Discriminant Theory of Linearly Separable Data, 2024, pp 249-294 from Springer

Abstract: Abstract This Chapter introduces three studies to confirm the correctness of cancer patients’ design three principles using four different sizes of microarrays. The first study (Study-1) evaluates three different sizes of microarrays, such as Liver3, Breast6, and Colorectal6. Colorectal6, having 63 patients, a medium-size array, has many “vital BGSs with M2 = 0 and less than five genes.” Study-2 analyzes Colorectal5 because it is almost the same size as Colorectal6. However, M2’s result of Colorectal5 is bad. Moreover, there are four misclassifications on the PCA scatterplot (Validation3). I omitted these four patients as test samples and got a great result from the modified Colorectal5 (44 patients (22:22)). Study-3 omitted the misclassifications by Validation3 and made five new microarrays, Liver300 (150:150), Liver200 (100:100), Liver100 (50:50 cancers), Liver60 (30:30), and Liver40 (20:20). Only Liver60 and Liver40 have many vital BGSs. These three studies conclude that the medium sample size microarrays are proper for cancer diagnosis because we can find many vital BGSs from those microarrays. Physicians can characterize vital BGSs by the legacy oncogenes included in them. Therefore, I propose new principles for cancer patients limited to gene diagnosis. These results open a new frontier of multivariate oncogenes for cancer gene diagnoses.

Keywords: Four Universal Data Structures of 169 microarrays; Liver3 (GSE14520; 357 patients); Breast6 (GSE42568; 116 patients); Colorectal5 (GSE25070; 48 patients); Colorectal6 (GSE8671; 63 patients); RIP of Program1; Program3 (SM decomposition); Program4 (BGS decomposition); Validation1 (Program2 10-fold CV); Validation2 (RatioSV); Validation3 (PCA scatterplot); Validation4 (Examine between vital BGS and legacy oncogenes by Physicians); Validation5 (Genome Cohort and Survival Analysis by Physicians); Three popular patient design principles; Cancer patients’ design three principles (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-981-99-9420-5_6

Ordering information: This item can be ordered from
http://www.springer.com/9789819994205

DOI: 10.1007/978-981-99-9420-5_6

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2026-06-19
Handle: RePEc:spr:sprchp:978-981-99-9420-5_6